BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31019021)

  • 1. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
    Ding S; Wu J; Lin C; Andriani L; Goh C; Chen W; Li Y; Shen K; Zhu L
    Oncologist; 2019 Nov; 24(11):e1014-e1023. PubMed ID: 31019021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
    Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
    J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The predicting value of the 8th edition of American Joint Committee on Cancer staging manual in mucinous breast cancer].
    Ding SN; Wu JY; Chen WG; Li YF; Shen KW; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):854-858. PubMed ID: 31770854
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication.
    Savage P; Yu N; Dumitra S; Meterissian S
    Eur J Surg Oncol; 2019 Oct; 45(10):1817-1820. PubMed ID: 30926158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Significance of the Oncotype DX Recurrence Score in T
    Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
    Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database.
    Li X; Zhang Y; Meisel J; Jiang R; Behera M; Peng L
    Breast Cancer Res Treat; 2018 Sep; 171(2):303-313. PubMed ID: 29948405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
    Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
    Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer.
    O'Cearbhaill R; Gannon JM; Prichard RS; Walshe JM; McDermott E; Quinn CM
    Pathobiology; 2019; 86(2-3):77-82. PubMed ID: 30347405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score System.
    Ding S; Zong Y; Lin C; Andriani L; Chen W; Liu D; Chen W; Li Y; Shen K; Wu J; Zhu L
    Front Oncol; 2020; 10():1471. PubMed ID: 33014784
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
    Mittendorf EA; Chavez-MacGregor M; Vila J; Yi M; Lichtensztajn DY; Clarke CA; Giordano SH; Hunt KK
    Ann Surg Oncol; 2017 Nov; 24(12):3502-3509. PubMed ID: 28726077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
    Chavez-MacGregor M; Mittendorf EA; Clarke CA; Lichtensztajn DY; Hunt KK; Giordano SH
    Oncologist; 2017 Nov; 22(11):1292-1300. PubMed ID: 28592619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.
    Jin ML; Gong Y; Pei YC; Ji P; Hu X; Shao ZM
    Breast; 2020 Feb; 49():93-100. PubMed ID: 31783315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Eighth American Joint Committee on Cancer Anatomic and Prognostic Staging System for Breast Cancer.
    Yang PD; Peng QQ; Lian WB; Fu FM; Wang C; Chen D
    J Surg Res; 2022 Feb; 270():539-546. PubMed ID: 34808473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.
    Weiss A; Chavez-MacGregor M; Lichtensztajn DY; Yi M; Tadros A; Hortobagyi GN; Giordano SH; Hunt KK; Mittendorf EA
    JAMA Oncol; 2018 Feb; 4(2):203-209. PubMed ID: 29222540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Breaux A; Turner B; Wu X; Rai SN; Riley EC; Mandadi M; Sanders MA
    Clin Breast Cancer; 2019 Feb; 19(1):e261-e269. PubMed ID: 30509870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.
    Yi M; Mittendorf EA; Cormier JN; Buchholz TA; Bilimoria K; Sahin AA; Hortobagyi GN; Gonzalez-Angulo AM; Luo S; Buzdar AU; Crow JR; Kuerer HM; Hunt KK
    J Clin Oncol; 2011 Dec; 29(35):4654-61. PubMed ID: 22084362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
    Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
    Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort.
    Cervera-Bonilla S; Rodríguez-Ossa P; Vallejo-Ortega M; Osorio-Ruiz A; Mendoza-Diaz S; Orozco-Ospino M; Lehmann-Mosquera C; Duarte-Torres C; Ángel-Aristizábal J; Guzmán-Abisaab L; Garcia-Mora M; Diaz-Casas S
    Ann Surg Oncol; 2021 Oct; 28(11):6014-6021. PubMed ID: 33830356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.
    Kurundkar A; Gao X; Zhang K; Britt JP; Siegal GP; Wei S
    Clin Breast Cancer; 2018 Dec; 18(6):e1347-e1352. PubMed ID: 30078612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30.
    Park S; Han Y; Liu Y; Toriola AT; Peterson LL; Colditz GA; Kim SI; Cho YU; Park BW; Park Y
    Breast Cancer Res; 2019 Oct; 21(1):110. PubMed ID: 31619259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.